Navigation Links
Luoxin Announces 2008 Third Quarterly Results; Profit Attributable to Shareholders Surged 62.9% to Approximately RMB 138,141,000
Date:10/28/2008

Obtained Shareholders' Approval on the Proposed Transfer of Listing of its

H Shares from GEM to the Main Board

HONG KONG, Oct. 28 /Xinhua-PRNewswire/ -- Shandong Luoxin Pharmacy Stock Co., Ltd. (HKEx: 8058), announced its third quarterly results for the nine months ended 30 September 2008, recording a strong growth in turnover and profit attributable to shareholders.

The Company's turnover rose 36.9% year-on-year to approximately RMB480,155,000, while gross profit increased by 45.6% to approximately RMB237,382,000. Profit attributable to shareholders surged by 62.9% to approximately RMB138,141,000. Basic earnings per share were RMB22.66 cents, representing an increase of 62.9% over the corresponding period in 2007.

As at 30 September 2008, the Company obtained a strong balance sheet with sufficient working capital and no debt.

During the period under review, the Company's Technology Center was certified as Province-Class Technology Center and joined forces with Shenyang Pharmacy University by establishing the Shenyang Pharmacy University and Luoxin Pharma post-doctorate workstation, Shenyang Pharmacy University and Luoxin Pharma education and training station, Shenyang Pharmacy University and Luoxin Pharma intern station. This cooperation has not only enhanced the technological advancement of Luoxin Pharma, but also served as a platform for technology interchange and nurture of talents, laying a solid foundation for the Company's future development.

In order to capture the huge market opportunity in the market, the Company's phase three capacity expansion plan has been completed and commenced operation. The production capacity of aseptic raw material and raw material for system-specific medicines has thus increased by 200 each.

Mr. Liu Baoqi, Chairman of Luoxin Pharma said, "The Company has recently obtained the shareholders' approval for the proposed transfer of listing of its H shares from GEM to the Main Board at the EGM and the respective Class Meetings on 24 October 2008. We believe that the listing on the Main Board not only helps further enhancing the profile of the Group and increases the trading liquidity of the Shares of the Company and recognition, but will also be of great benefit to future growth and business development of Luoxin Pharma in the long run."

For further information, please contact:

Porda International (Finance) PR Group

Ms. Kelly Fung

Tel: +852-3150-6763

Ms. Kate Lam

Tel: +852-3150-6738


'/>"/>
SOURCE Shandong Luoxin Pharmacy Stock Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. UCB Announces 2008 UCB Family RA Scholarship Program Recipients
2. QLT announces third quarter results for 2008
3. QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System
4. Response Biomedical Announces Insider Participation in Current Financing
5. American National Announces Third Quarter 2008 Results
6. Digestive Care, Inc. Announces the Complete Submission of the NDA for PANCRECARB(R) (pancrelipase)
7. U.S. Preventive Medicine(R) Announces Major Development for The Prevention Plan(TM)
8. Haemonetics Announces Promotion of Brian Concannon to CEO Effective April 2009
9. HLTH Corporation Announces Commencement of Its Tender Offer
10. ReachMD XM 157 Announces Medical Information Feature on Treatment Options for Management of Hyponatremia
11. Memory Pharmaceuticals Announces Issuance of Key U.S. Patent for R3487/MEM 3454 and R4996/MEM 63908
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy ... the preferred physical therapy provider for Derby City CrossFit, effective immediately. , In ... as quickly and effectively as possible, ProRehab’s sports physical therapists will work with ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump ... preparing for how his administration could impact the employee benefits industry. James Slotnick, ... are most likely to make it through Congress. His discussion will focus on ...
(Date:4/25/2017)... , ... April 25, 2017 , ... Lake Park Dental ... by using Invisalign® in Lutz, FL. With the help of this highly-effective, ... aesthetics with fewer potential complications, more discretion and less pain. , Drs. Sarah ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as well ... society for this important science. , The Teratology Society is ...
(Date:4/25/2017)... ... ... MD is committed to providing the highest quality of spine care to all his patients. ... all my patients to alleviate possible future issues. I am pleased to have you as ... my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary is ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... ZappRx, Inc ., a digital health company focused on modernizing ... closed $25 million in Series B funding led by Qiming ... Seattle that is part of a broader ... round included participation from SR One , who led ... (formerly Google Ventures). As part of the financing, Mark ...
(Date:4/20/2017)... April 20, 2017 Eyevensys, a ... first non-viral gene expression technology that enables the safe, ... to address a wide range of ophthalmic diseases, announces ... Healthcare products Regulatory Agency (MHRA) to advance its technology ... ...
Breaking Medicine Technology: